/

Empresas

Pu

No verificado

PureTech Health plc

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludSanidad

58 Comunicados de prensa

Ver todos los comunicados de prensa

29/04/2026

Mercado de valores

Web y redes sociales

Telefonía

Técnica

Medicina - Varios

Software

Biotecnología

Sanidad

Farmacéutica

Salud

Oncología

PureTech Announces Annual Results for Year Ended December 31, 2025

Fuente

PureTech Health plc

Editor

1.00

0

29/04/2026

Salud

Sanidad

Ciencia

Farmacéutica

Biotecnología

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

Fuente

PureTech Health plc

Editor

1.00

0

27/04/2026

Mercado laboral

Biotecnología

Sanidad

Salud

Farmacéutica

Medicina - Varios

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

Fuente

PureTech Health plc

Editor

1.00

0

22/04/2026

Industria

Ciencia

Biotecnología

Farmacéutica

Oncología

Salud

Higiene alimentaria

Medicina - Varios

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

Fuente

PureTech Health plc

Editor

1.00

0

13/04/2026

Mercado de valores

Finanzas

Web y redes sociales

Telefonía

Salud

Sanidad

Ciencia

Farmacéutica

Biotecnología

PureTech Health: Notice of Results

Fuente

PureTech Health plc

Editor

1.00

0

02/04/2026

Industria

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Sanidad

PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine

Fuente

PureTech Health plc

Editor

1.00

0

02/04/2026

Industria

Salud

Medicina - Varios

Sanidad

Farmacéutica

Biotecnología

PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers

Fuente

PureTech Health plc

Editor

1.00

0

25/03/2026

Industria

Biotecnología

Sanidad

Salud

Farmacéutica

Medicina - Varios

PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans

Fuente

PureTech Health plc

Editor

1.00

0

25/02/2026

Eventos

Web y redes sociales

Sanidad

Farmacéutica

Salud

PureTech to Present at the Leerink Partners Global Healthcare Conference

Fuente

PureTech Health plc

Editor

1.00

0

19/02/2026

Industria

Higiene alimentaria

Salud

Ciencia

Farmacéutica

Biotecnología

PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

Fuente

PureTech Health plc

Editor

1.00

0

Seguidores

0

Compatibilidad

0